Idera Pharmaceuticals, Inc.
(NASDAQ : IDRA)

( )
IDRA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 1.01%137.620.0%$902.91m
AMGNAmgen, Inc. 0.62%249.041.5%$834.11m
GILDGilead Sciences, Inc. -0.28%63.661.0%$540.48m
VRTXVertex Pharmaceuticals, Inc. 3.77%268.351.9%$479.39m
REGNRegeneron Pharmaceuticals, Inc. 3.14%681.912.6%$435.36m
ILMNIllumina, Inc. 0.65%245.073.3%$315.83m
NVAXNovavax, Inc. -3.78%51.4075.7%$295.88m
BIIBBiogen, Inc. -0.13%199.401.8%$239.75m
BNTXBioNTech SE 0.14%163.220.0%$226.72m
SNSSSunesis Pharmaceuticals, Inc. -0.47%2.100.7%$146.80m
EXASEXACT Sciences Corp. -2.20%52.0017.7%$143.85m
TXG10X Genomics, Inc. -0.80%49.760.0%$100.48m
TECHBio-Techne Corp. -0.50%364.514.5%$100.29m
NKTXNkarta, Inc. 0.79%12.770.0%$100.05m
BMRNBioMarin Pharmaceutical, Inc. 0.80%80.364.2%$99.19m

Company Profile

Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.